ACE inhibitors versus AT(1) receptor antagonists in patients with chronic renal disease.

@article{Hilgers2002ACEIV,
  title={ACE inhibitors versus AT(1) receptor antagonists in patients with chronic renal disease.},
  author={Karl Friedrich Hilgers and Johannes F. E. Mann},
  journal={Journal of the American Society of Nephrology : JASN},
  year={2002},
  volume={13 4},
  pages={1100-8}
}
The success of Angiotensin-converting enzyme (ACE) inhibitors in preventing the progression of chronic renal insufficiency has led investigators to study the effects of other inhibitors of the renin-angiotensin system (RAS). Recently, the results of the first large-scale trials with angiotensin II type 1 receptor (AT1) antagonists became available (1,2). This article discusses the relative merits of ACE inhibitors, AT1 antagonists, and the combination of both drug classes in the treatment of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

Update in nephrology.

Annals of internal medicine • 2004
View 7 Excerpts
Highly Influenced

IgA nephropathy

Iga Nephropathy
Nature Reviews Disease Primers • 2016

The pathogenesis and treatment of cardiac atrophy in cancer cachexia.

American journal of physiology. Heart and circulatory physiology • 2016
View 1 Excerpt

Inhibition of RAS in diabetic nephropathy

International journal of nephrology and renovascular disease • 2015
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 62 references

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

American journal of kidney diseases : the official journal of the National Kidney Foundation • 2001

Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice.

Proceedings of the National Academy of Sciences of the United States of America • 2001
View 1 Excerpt

Similar Papers

Loading similar papers…